Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia
The Journal of Infectious Diseases · 14.11.2025 · 232 (5) · 1061-1066
DOI: 10.1093/infdis/jiaf367 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 09.07.2025. Verfasst von Anna Farrell-Sherman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Viremia, Monocytes, HIV-1, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gates Foundation, National Institute of Allergy and Infectious Diseases, NCI NIH HHS.
Abstract (Originalsprache)
The persistence of human immunodeficiency virus 1 (HIV-1) proviruses in latently infected cells allows viremia to resume upon treatment cessation. To characterize the resulting immune response, we compared plasma proteomics and single-cell transcriptomics of peripheral blood mononuclear cells before, during, and after detectable plasma viremia. We observed unique transcriptional signatures prior to viral rebound, including a significant increase in CD16++ monocytes with increased antiviral gene expression. Inflammatory proteins were identified in plasma after detectable rebound. Identifying early signals of imminent viral rebound after treatment cessation will aid in the development of strategies to prolong time to viral rebound and cure HIV-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Molecular and Cellular Biology PhD Program, University of Washington, Seattle, Washington, USA.
- Department of Medicine, University of California San Francisco, San Francisco, California, USA.
- Laboratory of Computational Biology and Bioinformatics, A.C. Camargo Cancer Center, Sao Paulo, Brazil.
- Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
ORCID-Profile: Natalia de la Force, Renan Valieris, Walker Azam, Israel Da Silva, Cassandra Thanh, Lillian B Cohn
Förderung
- Gates Foundation
- National Institute of Allergy and Infectious Diseases
- NCI NIH HHS
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
Zitieren
APA
Farrell-Sherman, A., de la Force, N., Prator, C. A., Valieris, R., Azam, W., Da Silva, I., Deeks, S. G., Thanh, C., Bosch, R. J., Henrich, T. J., & Cohn, L. B. (2025). Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia. The Journal of Infectious Diseases, 232(5), 1061-1066. https://doi.org/10.1093/infdis/jiaf367
Vancouver
Farrell-Sherman A, de la Force N, Prator CA, Valieris R, Azam W, Da Silva I, et al. Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia. The Journal of Infectious Diseases. 2025;232(5):1061-1066. doi:10.1093/infdis/jiaf367
BibTeX
@article{FarrellSherman2025,
author = {Farrell-Sherman, Anna and de la Force, Natalia and Prator, Cecilia A and Valieris, Renan and Azam, Walker and Da Silva, Israel and Deeks, Steven G and Thanh, Cassandra and Bosch, Ronald J and Henrich, Timothy J and Cohn, Lillian B},
title = {Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {5},
pages = {1061--1066},
doi = {10.1093/infdis/jiaf367}
}
EUVIMED